4.6 Article

A Scalable Synthesis of Roxadustat (FG-4592)

Journal

ORGANIC PROCESS RESEARCH & DEVELOPMENT
Volume 26, Issue 3, Pages 915-924

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.oprd.1c00281

Keywords

roxadustat; isoquinoline synthesis; HIF inhibitors; scalable protocol; API synthesis; pharmaceutical quality

Ask authors/readers for more resources

A scalable five-step synthesis protocol was developed for the synthesis of roxadustat, focusing on medicinal chemistry aspects. The isoquinoline core of the molecule was prepared using a specifically designed cyclocondensation reaction, where both the condensation and demasking of groups were facilitated by a common acid agent in a single step. Roxadustat was obtained in high overall yield and met the permissible residual Pd level in API.
A scalable five-step protocol for synthesis of roxadustat, an orally administered h oxia-inducible factor-propyl hydroxylase inhibitor (HIF-PHI), was developed with an emphasis placed on aspects of medicinal chemistry. The isoquinoline core of the molecule was prepared using a purposefully designed cyclocondensation in which both the cyclocondensation and demasking of the groups being condensed is promoted by a common acid agent in one step. Roxadustat was obtained pure in a very competitive overall yield across all reaction steps and in compliance with permissible residual Pd level in API.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available